Author:
Gabriel Ledesma,Begoña Rivas,Cristina Vega,Gilda Carreño,Raquel Díaz,Ángel Gallegos,Verónica Mercado,Silvia Caldés,Yesika Amezquita,Yolanda Hernández,Rocío Echarri,Covadonga Hevia,Antonio Cirugeda
Publisher
Heighten Science Publications Corporation
Reference10 articles.
1. 1. World Health Organization. 2018. http://www.who.int/intestinal_worms/epidemiology/strongyloidiasis/en/
2. 2. Pacheco-Tenza MI, Ruiz-Maciá JA, Navarro-Cots M, Gregori-Colomé J, Cepeda-Rodrigo JM, Llenas-García J. Strongyloides stercoralis en un hospital comarcal del Levante español: una enfermedad no solo importada. Enferm Infecc Microbiol Clin. 2017.
3. 3. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007 Dec;41(12):1992-2001. doi: 10.1345/aph.1K302. Epub 2007 Oct 16. PMID: 17940124.
4. 4. Malakoutian T, Mohammadi R, Asgari M, Amouzegar A. Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report. Iran J Parasitol. 2015 Jan-Mar;10(1):141-5. PMID: 25904959; PMCID: PMC4403535.
5. 5. Gluhovschi G, Gluhovschi C, Velciov S, Ratiu I, Bozdog G, Taban S, Petrica L. "Surprise" in the evolution of chronic membranoproliferative glomerulonephritis associated with severe strongyloidiasis under corticotherapy: "hygienic paradox"? Ren Fail. 2013 Aug;35(7):1017-23. doi: 10.3109/0886022X.2013.810103. Epub 2013 Jul 5. PMID: 23826871.